RegenXBio's total assets for Q3 2025 were $525.20M, a decrease of -9.61% from the previous quarter. RGNX total liabilities were $363.75M for the fiscal quarter, a -0.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.